These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 15907584)

  • 61. Predicting drug release and degradation kinetics of long-acting microsphere formulations of tacrolimus for subcutaneous injection.
    Gao GF; Ashtikar M; Kojima R; Yoshida T; Kaihara M; Tajiri T; Shanehsazzadeh S; Modh H; Wacker MG
    J Control Release; 2021 Jan; 329():372-384. PubMed ID: 33271202
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Drug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model.
    Laroui H; Dalmasso G; Nguyen HT; Yan Y; Sitaraman SV; Merlin D
    Gastroenterology; 2010 Mar; 138(3):843-53.e1-2. PubMed ID: 19909746
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Nanoparticles in inflammatory bowel disease: particle targeting versus pH-sensitive delivery.
    Meissner Y; Pellequer Y; Lamprecht A
    Int J Pharm; 2006 Jun; 316(1-2):138-43. PubMed ID: 16675176
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Preparation and Characterization of a Novel Multiparticulate Dosage Form Carrying Budesonide-Loaded Chitosan Nanoparticles to Enhance the Efficiency of Pellets in the Colon.
    Soltani F; Kamali H; Akhgari A; Ghasemzadeh Rahbardar M; Afrasiabi Garekani H; Nokhodchi A; Sadeghi F
    Pharmaceutics; 2022 Dec; 15(1):. PubMed ID: 36678698
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Adalimumab Decorated Nanoparticles Enhance Antibody Stability and Therapeutic Outcome in Epithelial Colitis Targeting.
    Ries M; Moulari B; Shetab Boushehri MA; Ali ME; Molnar D; Béduneau A; Pellequer Y; Lamprecht A
    Pharmaceutics; 2022 Feb; 14(2):. PubMed ID: 35214083
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Prevention of vascular-allograft rejection by protecting the endothelial glycocalyx with immunosuppressive polymers.
    Siren EMJ; Luo HD; Tam F; Montgomery A; Enns W; Moon H; Sim L; Rey K; Guan Q; Wang JJ; Wardell CM; Monajemi M; Mojibian M; Levings MK; Zhang ZJ; Du C; Withers SG; Choy JC; Kizhakkedathu JN
    Nat Biomed Eng; 2021 Oct; 5(10):1202-1216. PubMed ID: 34373602
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Development and Characterization of a Tacrolimus/Hydroxypropyl-β-Cyclodextrin Eye Drop.
    García-Otero X; Díaz-Tomé V; Varela-Fernández R; Martín-Pastor M; González-Barcia M; Blanco-Méndez J; Mondelo-García C; Bermudez MA; Gonzalez F; Aguiar P; Fernández-Ferreiro A; Otero-Espinar FJ
    Pharmaceutics; 2021 Jan; 13(2):. PubMed ID: 33498753
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Advances in Oral Drug Delivery for Regional Targeting in the Gastrointestinal Tract - Influence of Physiological, Pathophysiological and Pharmaceutical Factors.
    Hua S
    Front Pharmacol; 2020; 11():524. PubMed ID: 32425781
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Nanoparticulate Drug Delivery Systems Targeting Inflammation for Treatment of Inflammatory Bowel Disease.
    Zhang S; Langer R; Traverso G
    Nano Today; 2017 Oct; 16():82-96. PubMed ID: 31186671
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Drug nanocarriers to treat autoimmunity and chronic inflammatory diseases.
    Prosperi D; Colombo M; Zanoni I; Granucci F
    Semin Immunol; 2017 Dec; 34():61-67. PubMed ID: 28855088
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Microparticles as controlled drug delivery carrier for the treatment of ulcerative colitis: A brief review.
    Nidhi ; Rashid M; Kaur V; Hallan SS; Sharma S; Mishra N
    Saudi Pharm J; 2016 Jul; 24(4):458-72. PubMed ID: 27330377
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Budesonide Loaded PLGA Nanoparticles for Targeting the Inflamed Intestinal Mucosa--Pharmaceutical Characterization and Fluorescence Imaging.
    Ali H; Weigmann B; Collnot EM; Khan SA; Windbergs M; Lehr CM
    Pharm Res; 2016 May; 33(5):1085-92. PubMed ID: 26718953
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Enhanced therapeutic efficacy of budesonide in experimental colitis with enzyme/pH dual-sensitive polymeric nanoparticles.
    Naeem M; Cao J; Choi M; Kim WS; Moon HR; Lee BL; Kim MS; Jung Y; Yoo JW
    Int J Nanomedicine; 2015; 10():4565-80. PubMed ID: 26213469
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Evaluation of In Vivo Transfection Efficiency of Eudragit Coated Nanoparticles of Chitosan-DNA: A pH-sensitive System Prepared for Oral DNA Delivery.
    Momenzadeh S; Sadeghi A; Vatandoust N; Salehi R
    Iran Red Crescent Med J; 2015 Apr; 17(4):e16761. PubMed ID: 26023332
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Micro and nanoparticle drug delivery systems for preventing allotransplant rejection.
    Fisher JD; Acharya AP; Little SR
    Clin Immunol; 2015 Sep; 160(1):24-35. PubMed ID: 25937032
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Nanomedicines in gastroenterology and hepatology.
    Lamprecht A
    Nat Rev Gastroenterol Hepatol; 2015 Apr; 12(4):195-204. PubMed ID: 25752711
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Formulation strategies for drug delivery of tacrolimus: An overview.
    Patel P; Patel H; Panchal S; Mehta T
    Int J Pharm Investig; 2012 Oct; 2(4):169-75. PubMed ID: 23580932
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Dextran sodium sulfate (DSS) induces colitis in mice by forming nano-lipocomplexes with medium-chain-length fatty acids in the colon.
    Laroui H; Ingersoll SA; Liu HC; Baker MT; Ayyadurai S; Charania MA; Laroui F; Yan Y; Sitaraman SV; Merlin D
    PLoS One; 2012; 7(3):e32084. PubMed ID: 22427817
    [TBL] [Abstract][Full Text] [Related]  

  • 79. IBD: selective nanoparticle adhesion can enhance colitis therapy.
    Lamprecht A
    Nat Rev Gastroenterol Hepatol; 2010 Jun; 7(6):311-2. PubMed ID: 20523352
    [No Abstract]   [Full Text] [Related]  

  • 80. Delivery of rapamycin to dendritic cells using degradable microparticles.
    Jhunjhunwala S; Raimondi G; Thomson AW; Little SR
    J Control Release; 2009 Feb; 133(3):191-7. PubMed ID: 19000726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.